Serum Induces the Subunit-Specific Activation of NF-κB in Proliferating Human Cardiac Stem Cells

Area of Science:

• Cardiovascular research
• Stem cell biology
• Molecular signaling

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death, often associated with aging.
• Declined proliferation of adult cardiac stem cells limits heart regeneration.
• Human blood serum has shown potential in enhancing cardiac stem cell proliferation and reducing senescence.

Purpose of the Study:

• To investigate the molecular signaling pathways responsible for serum-mediated proliferation of adult human cardiac stem cells (hCSCs).
• To identify key factors involved in enhancing hCSC proliferative potential for improved cell-based cardiovascular therapies.

Main Methods:

• Utilized the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) to probe the role of NF-κB in hCSC proliferation.
• Employed RNA-Sequencing (RNA-Seq) to analyze gene expression changes in response to serum treatment and NF-κB inhibition.

Main Results:

• Demonstrated the involvement of the transcription factor NF-κB in serum-induced hCSC proliferation.
• Identified ATF6B, COX5B, and TNFRSF14 as potential NF-κB target genes implicated in serum-mediated hCSC proliferation.

Conclusions:

• NF-κB signaling is a critical mediator of serum-induced proliferation in adult human cardiac stem cells.
• Targeting NF-κB and its downstream genes (ATF6B, COX5B, TNFRSF14) may offer novel therapeutic strategies for cardiovascular diseases.